Anna MacDonald
Science Writer
After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Latest Content
Industry Insight
Developing a Sustainable Source of Squalene
Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.
Industry Insight
Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future
Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Industry Insight
Driving Forward Huntington’s Disease Research
Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
Industry Insight
New Model Will Support Drug Discovery for Liver Disease NASH
To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
Industry Insight
Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors
Technology Networks spoke to Renee Ryan, Cala Health's CEO, to learn more about bioelectronic medicine and its use as a therapy for essential tremors.
Industry Insight
Probing the Proteome With Engineered Nanoparticles
In this interview, Dr. Daniel Hornburg discusses how engineered nanoparticles could help to bridge the gap between proteomics and genomics and transform cancer diagnostics.
Industry Insight
Identifying Risk Factors for Long COVID With Single-Cell Proteomics
In this interview we speak to Sean Mackay, CEO of IsoPlexis, to discuss how single-cell functional proteomics have helped researchers understand the risk factors behind long COVID.
Industry Insight
Using Bioelectronic Assays To Advance Drug Discovery for Neurological Diseases
In this interview, Jim Ross highlights several recent examples of how bioelectronic assays are helping to advance drug discovery for neurological diseases ranging from pediatric epilepsy to Burning Man Syndrome.
Industry Insight
Developing Novel Liquid Biopsy Oncology Tests
In this interview, Aiguo Zhang discusses some of the technologies that DiaCarta has developed within the liquid biopsy space and shares his thoughts on what the future may hold for the field.
Industry Insight
Time for Proteomics To Shine
Technology Networks had the pleasure of interviewing Dr. Oliver Rinner, CEO at Biognosys, to learn more about some of the recent developments in proteomics, and discuss what the future could hold for the field.
Advertisement